Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors

NCT00488878RecruitingOBSERVATIONAL

Summary

Key Facts

Lead Sponsor

M.D. Anderson Cancer Center

Enrollment

2000

Start Date

2006-05-19

Completion Date

2034-05-01

Study Type

OBSERVATIONAL

Official Title

Data Collection for Patients With Low Grade Ovarian Carcinoma

Interventions

Biospecimen CollectionElectronic Health Record Review

Conditions

Low Grade Ovarian Serous AdenocarcinomaMalignant Ovarian NeoplasmOvarian CarcinomaPrimary Peritoneal CarcinomaPrimary Peritoneal Low Grade Serous AdenocarcinomaPsammocarcinoma

Eligibility

Sex

FEMALE

Inclusion Criteria:

* Patients whose disease progressed to a higher-grade carcinoma since the time of original diagnosis:

  * Ovarian tumor of low malignant potential
  * Low-grade serous carcinoma of the ovary
  * Primary peritoneal tumor of low malignant potential
  * Low-grade serous carcinoma of the peritoneum
  * Psammocarcinoma

Outcome Measures

Primary Outcomes

Prospective and retrospective data collection on disease characterization, treatment, and outcomes

Time frame: Up to 28 years

Organization of clinical information

Will be done in order to support multifaceted queries of patient characteristics, treatment, and disease outcome data and to facilitate correlation of these characteristics with patient outcome.

Time frame: Up to 28 years

Creation of a single data repository to integrate clinical information and research findings

Time frame: Up to 28 years

Secondary Outcomes

Collection and storage of human tumor samples for the establishment of a tumor bank

Time frame: Up to 28 years

Locations

M D Anderson Cancer Center, Houston, United States